Effect of Oral Linoleic and γ-Linolenic Acid on Meibomian Gland Dysfunction
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
PURPOSE: To assess the effect of oral linoleic and gamma-linolenic acid, 2 omega-6 essential fatty acids, on meibomian gland dysfunction (MGD). METHODS: Fifty-seven patients with MGD (27 men and 30 women) were randomly divided into 3 groups of 19. Group A received tablets containing linoleic acid (28.5 mg) and gamma-linolenic acid (15 mg) once daily. Group B performed eyelid hygiene once daily. Group C received both treatments. Initially and after 60 and 180 days of therapy, all patients completed a self-evaluation questionnaire on ocular surface disorders and underwent slit-lamp examination. The following signs were evaluated: eyelid edema, eyelid margin hyperemia, meibomian secretion appearance, meibomian gland obstruction, foam collection in the tear meniscus, conjunctival hyperemia, conjunctival papillae, and corneal staining. RESULTS: Statistically significant improvement in symptoms occurred in all groups. After 180-day therapy, group A showed significant reduction in secretion turbidity (P = 0.02) and meibomian gland obstruction (P = 0.0001), whereas group B had significant reduction in eyelid edema (P = 0.02), corneal staining (P = 0.01), secretion turbidity (P = 0.01), and meibomian gland obstruction (P = 0.0001). Group C had significant reduction in eyelid edema (P = 0.003), foam collection in the tear meniscus (P = 0.02), corneal staining (P = 0.02), secretion turbidity (P = 0.0001), and meibomian gland obstruction (P = 0.0001). CONCLUSIONS: Therapy with linoleic and gamma-linolenic acid tablets along with eyelid hygiene improves symptoms and reduces eyelid margin inflammation in MGD more than either omega-6 fatty acids or eyelid hygiene alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345 · cited 1×
“PGE1 possesses several anti-inflammatory properties, including inhibition of superoxide, tumor necrosis factor, interleukin-1b, and interleukin 6.(14) Furthermore, 15-OH-DGLA inhibits 5-lipoxygenase, thus reducing the production of arachidonic acid–derived eicosanoids with proinflammatory properties, such as leukotrie…”
BackgroundThe Mediterranean diets: what is so special about the diet of Greece? The scientific evidence
Simopoulos, A. P. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.11.3065s · Cited by 473 · cited 1×
“In the Mediterranean diet, there is a balanced ratio of v-6/v-3 fatty acids (;4:1), whereas in the American and Northern European diets, there is an unhealthy overabundance of v-6 fatty acids, with ratios ranging from 15:1 to 18:1.(17) As a result, supplements containing linoleic and g-linolenic acid should be avoided…”
Background
Cited by
TFOS DEWS II Management and Therapy Report
Jones, L., Downie, L. E., Korb, D., Benitez-del-Castillo, J. M., Dana, R., Deng, S. X., Dong, P. N., Geerling, G., Hida, R. Y., Liu, Y., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.006 · Cited by 1,422
Effect of Oral Re-esterified Omega-3 Nutritional Supplementation on Dry Eyes
Epitropoulos, A. T., Donnenfeld, E. D., Shah, Z. A., Holland, E. J., Gross, M., Faulkner, W. J., Matossian, C., Lane, S. S., Toyos, M., Bucci, F. A., et al. (2016) · Cornea · doi:10.1097/ico.0000000000000940 · Cited by 114
A randomized controlled trial of omega-3 fatty acids in dry eye syndrome.
(2013) · PubMed Central · doi:10.3980/j.issn.2222-3959.2013.06.13 · Cited by 101
Malhotra, C., Singh, S., Chakma, P., & Jain, A. K. (2015) · Cornea · doi:10.1097/ico.0000000000000446 · Cited by 32
Metadata
- Authors
- Pinna, A., Piccinini, P., & Carta, F.
- Venue
- Cornea
- Published
- 2007-04
- Volume
- 26
- Issue
- 3
- Pages
- 260-264
- ISSN
- 0277-3740 (ISSN-L)
- OpenAlex
- W2150500509
- Cited by
- 71
- References
- 2
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.